| 序号 | 标题 | 次数 | 作者 | 发布时间 |
|---|---|---|---|---|
| 93601 | DOTA-cyclo(RGDyK) DOTA标记多肽 | 259 | zyl | 2024-11-21 |
| 93602 | C8-鞘氨醇,cas:133094-50-5,C8-Sphingosine | 241 | zcy | 2024-11-21 |
| 93603 | cyclo(RGDFK(DOTA)),DOTA-c(RGDfK) | 167 | wyh | 2024-11-21 |
| 93604 | Gd-DOTA-多肽 | 356 | zyl | 2024-11-21 |
| 93605 | 大环配体多肽DOTA-奥曲肽 | 178 | wyh | 2024-11-21 |
| 93606 | C8-C13异构醇,cas:68989-27-5,Alcohols, C8-13-iso- | 250 | zcy | 2024-11-21 |
| 93607 | 螯合剂DOTA修饰聚合物 | 221 | zyl | 2024-11-21 |
| 93608 | 微球接枝DOTA螯合剂 | 268 | zyl | 2024-11-21 |
| 93609 | DOTA-3-酪氨酰基-奥曲肽 ;177943-89-4 | 156 | wyh | 2024-11-21 |
| 93610 | 偶联功能基团的双功能螯合剂NOTA | 192 | zyl | 2024-11-21 |
| 93611 | DOTA-CH2-Alkynyl ;TFA salt | 169 | wyh | 2024-11-21 |
| 93612 | 双功能螯合剂NOTA偶联糖类化合物 | 177 | zyl | 2024-11-21 |
| 93613 | DOTA-TATE, 177943-88-3,DOTA-奥曲肽 | 259 | wyh | 2024-11-21 |
| 93614 | 依多曲肽 ;204318-14-9 ;DOTA-(Tyr3)-Octreotide | 170 | wyh | 2024-11-21 |
| 93615 | C13-DBCO的化学结构 | 201 | wyh | 2024-11-21 |
| 93616 | C8神经酰胺-1-磷酸;CAS:887353-95-9;C8 Ceramide-1-phosphate | 306 | zcy | 2024-11-21 |
| 93617 | DOTA-Glu-[cyclo (Arg-Gly-Asp-d-Phe-Lys)] | 159 | wyh | 2024-11-21 |
| 93618 | 大环配体化合物Gd-DOTA-RGD NOTA/NOTA-PEG-多肽 | 157 | wyh | 2024-11-21 |
| 93619 | 萨力多胺-O-C8-氨基盐酸盐,cas:2636798-38-2,Thalidomide-O-C8-NH2 hydrochloride | 168 | zcy | 2024-11-21 |
| 93620 | TOC奥曲肽修饰 ; 68Ga-DOTA-Ingr | 187 | wyh | 2024-11-21 |
| 93621 | DOTA-Ala-Ala-Tyr-COOH ;DOTA-丙氨酸-丙氨酸-酪氨酸-羧酸 | 190 | wyh | 2024-11-21 |
| 93622 | cyclo(RGDFK(DOTA))的性质与特点 | 169 | wyh | 2024-11-21 |
| 93623 | 96960-92-8;1-O-十六烷基-2-O-甲基-SN-甘油;Hexadecyl Methyl Glycerol | 232 | zcy | 2024-11-21 |
| 93624 | FITC标记TAT穿膜肽 ;Gd-DTPA-ACPP | 131 | wyh | 2024-11-21 |
| 93625 | DOTA-Octreotide ;DOTA-奥曲肽 | 138 | wyh | 2024-11-21 |
| 93626 | 螯合剂多肽cyclo(RGDFK(DOTA)) ;DOTA-c(RGDfK) | 152 | wyh | 2024-11-21 |
| 93627 | DOTA-JR10多肽的结构特点 | 194 | wyh | 2024-11-21 |
| 93628 | Biotin-Gd-DOTA ;生物素修饰的钆 | 178 | wyh | 2024-11-21 |
| 93629 | c18 peg-ifn;C18脂肪酸-聚乙二醇-干扰素 | 176 | zcy | 2024-11-21 |
| 93630 | DOTA-Tyr-Lys-DOTA的应用 | 145 | wyh | 2024-11-21 |
| 93631 | c18聚乙二醇6000(peg6000)是什么? | 476 | zcy | 2024-11-21 |
| 93632 | NOTA-E(cRGDfK)2 NOTA修饰多肽 | 162 | wyh | 2024-11-21 |
| 93633 | DOTA-c(RGDfK) 螯合物前体多肽 | 159 | wyh | 2024-11-21 |
| 93634 | 脂肪酸聚乙二醇酯的作用 | 499 | zcy | 2024-11-21 |
| 93635 | DOTA-奥曲肽 ;DOTA-Octreotide | 145 | wyh | 2024-11-21 |
| 93636 | 卤代烷的N-烷基化反应机理的简要介绍 | 1624 | zcy | 2024-11-21 |
| 93637 | DOTA-octreotide,DOTA-奥曲肽 ,大环配体多肽 | 150 | wyh | 2024-11-21 |
| 93638 | N2烷基化反应原理的简介 | 451 | zcy | 2024-11-21 |
| 93639 | DOTA-多肽分子探针 ;RGD多肽偶联的酞菁硅光敏剂 | 194 | wyh | 2024-11-21 |
| 93640 | 含烷基链环多胺衍生物是什么? | 202 | zcy | 2024-11-21 |
| 93641 | 1293368-74-7 ;DOTA标记的多肽 | 122 | wyh | 2024-11-21 |
| 93642 | 含烷基链的氨基酸甲酯类化合物有哪些? | 226 | zcy | 2024-11-21 |
| 93643 | DOTA标记多肽 ;DOTA-cyclo(RGDyK) | 139 | wyh | 2024-11-21 |
| 93644 | DOTA修饰的药物分子的结构与特性 | 188 | wyh | 2024-11-21 |
| 93645 | 官能团功能化大环配体DOTA的应用 | 141 | wyh | 2024-11-21 |




齐岳微信公众号
官方微信
库存查询